Is there any way Avastin could now be obtained through the NHS apart from as part of a trial? And is there any way of predicting yet who will benefit clinically from having Avastin?
Avastin (bevacizumab) is available in England via the cancer drugs fund for women with stage 3B/ 3C ovarian cancer where there is residual disease of over 1cm, or for women with stage 4 ovarian cancer. This is not within a clinical trial.
There is currently no validated way of predicting who will respond best to Avastin.
As well as being available for some women in England, women with stage 4 ovarian cancer in Scotland are able to access Avastin (bevacizumab) via the NHS.
It’s not currently available in Wales or Northern Ireland although we expect to hear more about its availability in Northern Ireland within the next year.